Tianan Pharmaceutical Co Stock Today

TNPH Stock  USD 0.01  0.00  0.00%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
Tianan Pharmaceutical is trading at 0.0052 as of the 24th of November 2024. This is a No Change since the beginning of the trading day. The stock's open price was 0.0052. Tianan Pharmaceutical has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Tianan Pharmaceutical Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of September 2024 and ending today, the 24th of November 2024. Click here to learn more.
Tianan Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. The company was founded in 2003 and is based in Xian, China. More on Tianan Pharmaceutical Co

Moving together with Tianan Pink Sheet

  0.74MKKGY Merck KGaA ADRPairCorr
  0.73MKGAF MERCK KommanditgesellsPairCorr
  0.76HLN Haleon plcPairCorr
  0.78TAK Takeda PharmaceuticalPairCorr

Moving against Tianan Pink Sheet

  0.73WMT Walmart Aggressive PushPairCorr
  0.35GMNFF GobiMinPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Tianan Pink Sheet Highlights

CEO and DirectorJianjun Weng
Business ConcentrationDrug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Tianan Pharmaceutical Co [TNPH] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Tianan Pharmaceutical's market, we take the total number of its shares issued and multiply it by Tianan Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Tianan Pharmaceutical conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. Tianan Pharmaceutical Co currently holds about 8.23 M in cash with 2.56 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.59, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Tianan Pharmaceutical Probability Of Bankruptcy

Tianan Pharmaceutical Risk Profiles

Tianan Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Tianan Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Rebalancing Now

   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Module

Tianan Pharmaceutical Corporate Management

Hailiang XueChief Production OfficerProfile
Andong JiaChief Admin. OfficerProfile
Huachu TangChief Investment OfficerProfile
Lie WeiChief OfficerProfile
Peng XiChief Marketing OfficerProfile
Renhua WangSecretaryProfile

Other Information on Investing in Tianan Pink Sheet

Tianan Pharmaceutical financial ratios help investors to determine whether Tianan Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tianan with respect to the benefits of owning Tianan Pharmaceutical security.